Waters Corporation (NYSE:WAT) SVP Rohit Khanna sold 26,913 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the transaction, the senior vice president now directly owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Rohit Khanna also recently made the following trade(s):

  • On Friday, September 8th, Rohit Khanna sold 18,400 shares of Waters Corporation stock. The shares were sold at an average price of $185.78, for a total transaction of $3,418,352.00.

Shares of Waters Corporation (WAT) opened at 199.75 on Monday. The company has a market capitalization of $15.94 billion, a PE ratio of 30.11 and a beta of 0.82. Waters Corporation has a 52 week low of $133.35 and a 52 week high of $199.78. The firm’s 50-day moving average is $185.39 and its 200 day moving average is $179.71.

Waters Corporation (NYSE:WAT) last issued its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, beating the consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million during the quarter, compared to analysts’ expectations of $555.25 million. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.57 EPS. On average, analysts anticipate that Waters Corporation will post $7.41 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Waters Corporation (WAT) SVP Sells 26,913 Shares of Stock” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/10/30/insider-selling-waters-corporation-wat-svp-sells-26913-shares-of-stock.html.

WAT has been the subject of several recent research reports. Bank of America Corporation reissued a “neutral” rating and issued a $192.00 price target (up previously from $180.00) on shares of Waters Corporation in a research report on Friday, July 21st. Wells Fargo & Company reissued an “outperform” rating and issued a $205.00 price target (up previously from $195.00) on shares of Waters Corporation in a research report on Thursday, July 13th. Jefferies Group LLC reissued a “hold” rating and issued a $170.00 price target on shares of Waters Corporation in a research report on Friday, July 14th. Barclays PLC increased their price target on shares of Waters Corporation from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Finally, Deutsche Bank AG increased their price target on shares of Waters Corporation from $199.00 to $200.00 and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $190.71.

Several large investors have recently modified their holdings of WAT. Janus Henderson Group PLC raised its position in shares of Waters Corporation by 20,670.6% in the 2nd quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock valued at $354,773,000 after buying an additional 1,920,502 shares in the last quarter. Koch Industries Inc. raised its position in shares of Waters Corporation by 36,932.0% in the 2nd quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock valued at $532,000 after buying an additional 533,298 shares in the last quarter. Fundsmith LLP raised its position in shares of Waters Corporation by 11.7% in the 2nd quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock valued at $704,834,000 after buying an additional 401,420 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its position in shares of Waters Corporation by 3,735.4% in the 1st quarter. Nomura Asset Management Co. Ltd. now owns 373,950 shares of the medical instruments supplier’s stock valued at $58,452,000 after buying an additional 364,200 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Waters Corporation by 214.5% in the 2nd quarter. Renaissance Technologies LLC now owns 526,400 shares of the medical instruments supplier’s stock valued at $96,773,000 after buying an additional 359,000 shares in the last quarter. Institutional investors own 91.08% of the company’s stock.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.